Philips India Unlisted Shares
Philips & ACTREC (Tata Memorial Cancer Centre) – Partner to Strengthen Early Cancer Detection in India
Bio Spectrum India
2 min read
Expert Analysis:
Philips has partnered with the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of Tata Memorial Centre, to strengthen early cancer detection capabilities in India through advanced imaging technology.
The collaboration introduces Philips Spectral CT 7500, an advanced imaging system that captures detailed spectral information during routine CT scans, enabling deeper disease characterisation from a single scan and supporting earlier and more confident diagnoses.
The technology allows full-body exams in about two seconds and research indicates it can lead to 36% fewer additional diagnostic procedures in complex cancer evaluations, reducing patient anxiety, radiation exposure, and delays in treatment.
The system is expected to support multiple specialties including oncology, cardiology, neurology, and emergency care, where faster and more accurate diagnostic insights can significantly improve treatment decisions and patient outcomes.
Key Takeaway:
The Philips–ACTREC collaboration brings next-generation Spectral CT technology into India’s cancer care ecosystem, enabling faster and more precise diagnosis, potentially reducing repeat procedures by 36% and improving clinical decision-making for complex cancer cases.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved